Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)
Phase 3
200
about 3.5 years
18+
1 site in TX
About this study
Researchers are testing two different mixtures of propofol and etomidate to see which one affects hemodynamics and causes fewer adverse events during anesthesia for endoscopic procedures. The trial will last 1289 days and involve approximately 200 adults.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Admixture of propofol and etomidate at a ratio by volume of 25%/75% (P2E7)
- 2.Take Admixture of propofol and etomidate at a ratio by volume of 75%/25% (P7E2)
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
general anesthetic (Facilitates GABA; induces unconsciousness), NERVOUS SYSTEM
injection (Injection)
Primary: % of cases with any oxygen saturation event below 85% by pulse oximetry, Within treatment arm % of total group with a classic MACE event in the 30 days, Within treatment arm % of total group with a composite MACE event in the 30 days
Secondary: Within each treatment arm number of classic MACE events in the 30 days, Within each treatment arm number of composite MACE events in the 30 days